COMMUNIQUÉS West-GlobeNewswire

-
Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib’s Unique, Dual Therapeutic Mechanism of Action
04/06/2025 -
Elicio Therapeutics Secures $10 Million in Financing
04/06/2025 -
BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments
04/06/2025 -
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
04/06/2025 -
aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
04/06/2025 -
Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream
04/06/2025 -
Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries
04/06/2025 -
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
04/06/2025 -
Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia®
04/06/2025 -
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26
04/06/2025 -
Aveanna Healthcare Holdings Completes Acquisition of Thrive Skilled Pediatric Care
04/06/2025 -
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
04/06/2025 -
The Joint Corp. Appoints Sandi Karrmann as Director
04/06/2025 -
Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
04/06/2025 -
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
04/06/2025 -
Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
04/06/2025 -
Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
04/06/2025 -
Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements
04/06/2025 -
Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2
04/06/2025
Pages